News Conference News VIVA 2016 Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear L.A. McKeown September 21, 2016
News Daily News ¿Bivalirudina?, ¿Heparina? Una Encuesta Revela que los Médicos se Dividen por las Opciones Antitrombóticas para PCI en el Manejo de STEMI Yael L. Maxwell September 15, 2016
News Daily News Bivalirudin? Heparin? Physicians Are Divided Over Antithrombotic Choices for PCI in STEMI, Survey Shows Yael L. Maxwell September 15, 2016
News Daily News Stroke Risk With TAVR: In-Depth Review of PARTNER and CoreValve Data Reveals Opportunities and Unknowns Shelley Wood September 13, 2016
News Conference News ESC 2016 Day or Night, STEMI Patients Receive Similar Levels of Quality Care L.A. McKeown August 31, 2016
News Conference News ESC 2016 Use of Antithrombotics Instead of Stents Appears Safe, Reduces Thrombus Burden in Subset of ACS Patients: EROSION Michael O'Riordan August 30, 2016
News Conference News ESC 2016 NORSTENT: Do Modern-day Bare-Metal Stents Stand Up to Drug-Eluting Stents? Shelley Wood August 30, 2016
News Conference News ESC 2016 DOCTORS: Optical Coherence Tomography Improves Stent Placement, Ups FFR in NSTE ACS Shelley Wood August 30, 2016
News Conference News ESC 2016 Platelet Function Testing to Guide Treatment Does Not Benefit Elderly ACS Patients: ANTARCTIC Todd Neale August 28, 2016
News Conference News ESC 2016 NIPPON: With Nobori Stent, 6 Months of DAPT as Safe and Effective as 18 Months Michael O'Riordan August 28, 2016
News Daily News Increased Risk of In-Hospital Complications, Including Mortality, Among A-fib Patients Undergoing PCI Michael O'Riordan August 24, 2016
News Opinion Editor's Corner ESC 2016: Bare-Metal Flashbacks, Coronary Imaging Comparisons, Heart Team Hype, and His Holiness Shelley Wood August 24, 2016
News Features The Bioresorbable Stent Story So Far: What Promise? What Price? Michael O'Riordan August 17, 2016
News Daily News Data Gap: Best Strategy Unknown for A-Fib Patients on Newer Anticoagulants Who Need PCI L.A. McKeown August 17, 2016
News Daily News Intracoronary Abciximab Shows Advantage in Diabetic STEMI Patients L.A. McKeown August 11, 2016
News Daily News ‘Reassuring’ 18-Month Results Seen With Absorb BVS, but Longer-Term Follow-up Still Needed Michael O'Riordan August 01, 2016
News Daily News Another Meta-Analysis Supports Prolonged Bivalirudin Use in STEMI, but Is Contemporary PCI Reflected? Yael L. Maxwell July 27, 2016